rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income
Operating income 115.35 85.14 71.22 42.47 43.36
Expenses
Material consumed 63.64 40.89 37.92 20.41 28.11
Manufacturing expenses 12.95 10.40 7.54 6.61 6.46
Personnel expenses 15.87 14.50 11.98 10.25 9.01
Selling expenses - 0.14 0.01 0.01 0.01
Adminstrative expenses 7.17 7.71 3.47 3.96 13.10
Expenses capitalised - - - - -
Cost of sales 99.63 73.65 60.92 41.24 56.69
Operating profit 15.72 11.49 10.30 1.23 -13.34
Other recurring income 3.27 2.10 0.75 0.26 0.65
Adjusted PBDIT 18.99 13.59 11.05 1.48 -12.68
Financial expenses 2.04 0.79 0.74 0.10 2.13
Depreciation 5.33 5.49 4.48 3.27 3.42
Other write offs - - - - -
Adjusted PBT 11.62 7.31 5.83 -1.88 -18.23
Tax charges 0.28 - - - 1.50
Adjusted PAT 11.34 - - - -19.73
Non recurring items 0.15 -2.16 - -23.33 -
Other non cash adjustments - - - - -
Reported net profit 11.49 5.15 5.83 -25.20 -19.73
Earnigs before appropriation -54.48 -66.01 -71.17 -76.99 -51.79
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings -54.48 -66.01 -71.17 -76.99 -51.79
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close